TrialThe Journal of infectious diseases2024

Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B/Victoria Virus Infections.

Wey Wen Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.